Mediq Acquires Mathot Medische Speciaalzaken in the Netherlands

The acquisition of Mathot reflects Mediq’s commitment to strengthening its position in the Dutch market and its vision to enable sustainable healthcare. This strategic step creates synergies that help meet the growing demand for care while maintaining and, where possible, enhancing the quality of care.

Arjen Linders, CEO of Mediq, said:
"The acquisition of Mathot is a significant step in Mediq’s strategy to reinforce our presence in the Netherlands. Mathot’s dedication to improving healthcare through high-quality products and value-added services aligns seamlessly with Mediq’s mission to deliver the best and most efficient outcomes for European healthcare. We are thrilled to welcome Mathot to the Mediq family."

Marcia Luijendijk, Managing Director for the Benelux region at Mediq, added:
"Today marks an exciting milestone for Mediq Netherlands as we continue to expand our presence in this vital healthcare market. I am delighted to welcome our new Mathot colleagues to the Mediq family and look forward to working together to drive future success and make a meaningful impact on healthcare in the Netherlands."

Antoine Hendrikx, Managing Director of Mathot, commented:
"I am confident that Mathot has a promising future with Mediq. Together, we will continue to innovate, delivering products, services, and solutions that help patients lead better-quality lives."

Mathot was previously a member of KMT Medical Europe, a network of 14 companies across 10 countries, providing home healthcare services to customers.